- Home
- CRIS vs PIII Comparison
CRIS vs PIII Comparison
Compare CRIS & PIII Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- PIII
- Stock Information
- Founded
- CRIS 2000
- PIII 2015
- Country
- CRIS United States
- PIII United States
- Employees
- CRIS N/A
- PIII N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- PIII Medical/Nursing Services
- Sector
- CRIS Health Care
- PIII Health Care
- Exchange
- CRIS Nasdaq
- PIII Nasdaq
- Market Cap
- CRIS 21.3M
- PIII 21.4M
- IPO Year
- CRIS 2000
- PIII N/A
- Fundamental
- Price
- CRIS $1.81
- PIII $6.23
- Analyst Decision
- CRIS Strong Buy
- PIII Buy
- Analyst Count
- CRIS 2
- PIII 2
- Target Price
- CRIS $16.50
- PIII $16.25
- AVG Volume (30 Days)
- CRIS 163.8K
- PIII 3.7K
- Earning Date
- CRIS 07-31-2025
- PIII 08-06-2025
- Dividend Yield
- CRIS N/A
- PIII N/A
- EPS Growth
- CRIS N/A
- PIII N/A
- EPS
- CRIS N/A
- PIII N/A
- Revenue
- CRIS $11,202,000.00
- PIII $1,485,192,000.00
- Revenue This Year
- CRIS N/A
- PIII N/A
- Revenue Next Year
- CRIS $10.67
- PIII $6.01
- P/E Ratio
- CRIS N/A
- PIII N/A
- Revenue Growth
- CRIS 14.17
- PIII 9.79
- 52 Week Low
- CRIS $1.02
- PIII $6.00
- 52 Week High
- CRIS $8.29
- PIII $32.54
- Technical
- Relative Strength Index (RSI)
- CRIS 43.58
- PIII 42.33
- Support Level
- CRIS $1.50
- PIII $6.00
- Resistance Level
- CRIS $1.98
- PIII $6.46
- Average True Range (ATR)
- CRIS 0.19
- PIII 0.21
- MACD
- CRIS -0.05
- PIII 0.07
- Stochastic Oscillator
- CRIS 43.88
- PIII 33.33
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About PIII P3 Health Partners Inc.
P3 Health Partners Inc is a patient-centered and physician-led population health management company. P3's model aggregates and supports the community's existing healthcare resources to build a network of community providers working together to deliver coordinated and integrated care to patients with a shared commitment to improving patient outcomes, lowering cost, and delivering experience for all.